Urology · Annapolis, MD
NPI
1699169169
Since 2015
Specialty
Urology
Code 208800000X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
600 Ridgely Ave Ste 130
Annapolis, MD, 21401
Phone (410) 266-8049
Groups this clinician bills Medicare through
Medicare paid, 2024
$361K
10,342 services
Medicare patients, 2024
1,124
Average age 76
Drug cost, 2024
$159K
761 prescriptions
Company payments, 2025
$5,361
From 28 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Fei Lian was code J9030 (bcg live intravesical instillation, 1 mg), 2,400 times for 26 patients. In total Fei Lian billed 10,342 services in 102 codes, and Medicare paid $361K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-10-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9030 Bcg live intravesical instillation, 1 mg | Office | 2,400 | 26 | $2.10 | $5,030 |
| 87798 Infectious Agent Detection by DNA/RNA | Office | 1,648 | 125 | $34.39 | $57K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 983 | 718 | $12.29 | $12K |
| 81002 Clinical Chemistry | Office | 963 | 721 | $3.36 | $3,231 |
| 99214 Office E&M - Established | Office | 742 | 556 | $91.21 | $68K |
| 51798 Ultrasound - Nonspecific | Office | 661 | 516 | $8.51 | $5,628 |
| 99213 Office E&M - Established | Office | 276 | 234 | $67.39 | $19K |
| 99204 Office E&M - New | Office | 175 | 175 | $121.83 | $21K |
| 87799 Infectious Agent Detection by DNA/RNA | Office | 134 | 125 | $41.98 | $5,625 |
| 87653 Infectious Agent Detection by DNA/RNA | Office | 134 | 125 | $34.39 | $4,608 |
| 87641 Infectious Agent Detection by DNA/RNA | Office | 134 | 125 | $34.39 | $4,608 |
| 87640 Infectious Agent Detection by DNA/RNA | Office | 133 | 124 | $34.39 | $4,574 |
| 87652 Infectious Agent Detection by DNA/RNA | Office | 132 | 123 | $40.92 | $5,401 |
| 87500 Infectious Agent Detection by DNA/RNA | Office | 120 | 113 | $34.39 | $4,127 |
| 87481 Infectious Agent Detection by DNA/RNA | Office | 105 | 98 | $34.39 | $3,611 |
By year: 2022 $278K for 8,173 services; 2023 $419K for 12,566 services; 2024 $361K for 10,342 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 87798 Infectious Agent Detection by DNA/RNA | 1,648 | 125 | $34.39 | $57K |
| 81002 Clinical Chemistry | 963 | 721 | $3.36 | $3,231 |
| 87799 Infectious Agent Detection by DNA/RNA | 134 | 125 | $41.98 | $5,625 |
| 87641 Infectious Agent Detection by DNA/RNA | 134 | 125 | $34.39 | $4,608 |
| 87653 Infectious Agent Detection by DNA/RNA | 134 | 125 | $34.39 | $4,608 |
| 87640 Infectious Agent Detection by DNA/RNA | 133 | 124 | $34.39 | $4,574 |
| 87652 Infectious Agent Detection by DNA/RNA | 132 | 123 | $40.92 | $5,401 |
| 87500 Infectious Agent Detection by DNA/RNA | 120 | 113 | $34.39 | $4,127 |
| 87481 Infectious Agent Detection by DNA/RNA | 105 | 98 | $34.39 | $3,611 |
| 87661 Infectious Agent Detection by DNA/RNA | 104 | 97 | $34.39 | $3,577 |
Medicare prescription drug claims, 2024
In 2024, the drug Fei Lian prescribed most often to Medicare patients was Tamsulosin Hcl, with 318 prescriptions and refills. In total Fei Lian wrote 761 Medicare prescriptions that cost $159K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 318 | 882 | 115 | $5,411 |
| Finasteride Generic | 59 | 171 | 21 | $977 |
| Gemtesa Vibegron | 41 | 121 | 17 | $57K |
| Cefuroxime Cefuroxime Axetil | 32 | 32 | 28 | $128 |
| Estradiol Generic | 28 | 57 | 17 | $1,703 |
| Ciprofloxacin Hcl Generic | 27 | 27 | 27 | $43.97 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 27 | 37 | 22 | $460 |
| Silodosin Generic | 22 | 60 | Under 11 | $2,345 |
| Solifenacin Succinate Generic | 21 | 39 | Under 11 | $4,075 |
| Myrbetriq Mirabegron | 19 | 45 | Under 11 | $19K |
| Potassium Citrate Er Potassium Citrate | 19 | 50 | Under 11 | $1,414 |
| Alfuzosin Hcl Er Alfuzosin Hcl | 18 | 54 | Under 11 | $407 |
| Testosterone Cypionate Generic | 15 | 38 | Under 11 | $560 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 12 | 12 | 11 | $30.97 |
| Cephalexin Generic | 11 | 25 | Under 11 | $119 |
Brand drugs: 84 claims; generic drugs: 677 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Fei Lian $5,361 ($5,361 in general payments such as food, travel and fees) from 28 companies. The largest payer was Pfizer Inc. with $1,752.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 7 | $1,752 |
| Janssen Scientific Affairs, LLC JNJ | 5 | $1,547 |
| Endo USA, Inc. | 9 | $291 |
| Dendreon Pharmaceuticals LLC | 5 | $247 |
| Janssen Biotech, Inc. JNJ | 8 | $225 |
| Johnson & Johnson Health Care Systems Inc. JNJ | 1 | $149 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $148 |
| Blue Earth Diagnostics | 2 | $116 |
| Immunitybio, Inc. IBRX | 2 | $115 |
| Sumitomo Pharma America, Inc. 4506.T | 4 | $113 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.